Mimetogen Pharmaceuticals is a late stage clinical biotechnology company focused on developing synthetic neurotrophin mimetics for treating ocular surface diseases with high unmet medical needs. Self-described efforts include advancing tavilermide for dry eye disease and developing treatments for ophthalmologic degenerative diseases.

Mimetogen Pharmaceuticals

Mimetogen Pharmaceuticals Inc. | 74 followers on LinkedIn. 

Cedric Bisson

Head of Research & Development | CMO | Board Member | Extensive Ophthalmology R&D & Commercial Experience

Kim Brazzell, PhD

Mimetogen Pharmaceuticals Inc.

Mimetogen Pharmaceuticals is a late stage clinical biotechnology company focused on developing synthetic neurotrophin mimetics for treating ocular surface diseases with unmet medical needs. The company is developing its lead compound, tavilermide, for dry eye disease.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 18, 2024 10:01 PM	a42f2f4d
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 18, 2024 10:01 PM	2d16bde1
crunchbase trigger	general	Nov 18, 2024 10:01 PM	03e14eb3
crunchbase profile	general
li profile	general	Nov 18, 2024 10:01 PM	cf5b09fd
translate crunchbase fundingrounds	general
peers	general	Nov 18, 2024 10:01 PM	b66e04f5
news basic	general	Nov 18, 2024 10:01 PM	2dada7f9
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

MIME

COM:MIMETOGEN

Mimetogen Pharmaceuticals